Tilray shares jump as stock buying pressure builds

Traders Union
All News
Financial News
Tilray gains 2.84% today to $7.06

Highlights

Tilray delivered steady Canadian performance last quarter while international operations and the beverage segment showed meaningful growth.
The company continues to invest in the cultivation, research, and sale of medicinal cannabis, supporting diversified revenue streams.
Technicals indicate a short-term bullish bias within a $6.73–$7.28 range, but overbought conditions and trend weakness suggest consolidation is likely.

International gains and beverage expansion buoy operational outlook

Following the latest quarterly results, Tilray reports stable performance in its Canadian operations and improvements in international markets, with notable growth in the beverage segment. The company remains active in the cultivation, research, and sale of medicinal cannabis.

Anton Kharitonov, expert at Traders Union, finds Tilray’s technical momentum fragile and overextended. He emphasizes persistent seller control long-term and sees overbought signals as a warning of exhaustion. The analyst notes that only one out of four weekly indicators supports further upside, reinforcing skepticism about sustained gains. He draws attention to medium-term averages and the risk of retracement towards $6.59 if support breaks. "Until Tilray can clear the $7.07–$7.28 resistance with conviction and see fundamental improvements, chasing upside looks premature given prevailing risks," says Kharitonov.

Viktoras Karapetjanc, expert at Traders Union, highlights strong fundamentals and international expansion as key positives for Tilray. He believes improved beverage segment growth and resilient Canadian operations position the company well. Karapetjanc sees the recent move above short-term averages as evidence the bullish structure remains intact. He expects further growth if momentum can overcome overhead resistance. "With multiple drivers in play, I see Tilray well-placed to capitalize on global cannabis adoption," Karapetjanc concludes.

Short-term bullish tilt holds as overbought signals warn of exhaustion

Tilray trades above its 20-day and 50-day moving averages at $6.58 and $7.07, but remains well below the 200-day at $9.72. This setup suggests a short-term bullish tilt with lingering medium- and long-term seller pressure; the nearest dynamic support is seen at the Ichimoku Kijun level of $6.59, with resistance likely at the $7.07 region.

Momentum is conflicted: MACD signals strong selling but the Average Directional Index (ADX) remains neutral, hinting at weak trend strength. Both the Relative Strength Index (RSI) and Commodity Channel Index (CCI) are in the overbought zone, while Stochastic RSI is also deeply overbought. Bull/Bear Power (BBP) is positive at 0.43, confirming buyers dominate intraday direction, even as overbought readings warn of potential exhaustion. The Awesome Oscillator (AO) supports the upward tone. Intraday, Tilray has risen 2.84% to $7.06 after opening with a slight downside gap and is holding near session highs. Intraday volatility stands at 3.22%, and price action reflects sustained strength toward the top of the day’s range.

Earlier, analysts noted that Tilray's short-term technical outlook was moderately bullish, but cautioned that medium- and long-term trends remained under pressure from sellers. The current data reinforces this caution, as persistent overbought signals and mixed momentum indicators suggest traders should monitor $7.07 as a pivotal resistance level for potential breakout or reversal in the coming sessions.

Source of Data: TLRY Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.